ZIMMER BIOMET HOLDINGS, INC.

Alpha Score of 44 reflects weak overall profile with moderate momentum, weak value, weak quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.

Zimmer Biomet Holdings, Inc. is a global medical technology company that designs, manufactures, and markets orthopedic reconstructive products for joint replacement and repair. The company provides a comprehensive portfolio including knee and hip implants, sports medicine and biologics products, extremities and trauma solutions, craniomaxillofacial and thoracic reconstructive products, spine implants, office-based surgical technologies, and dental implants. Zimmer Biomet serves patients, surgeons, and healthcare systems across multiple geographical markets including the Americas, Europe, Middle East, Africa, and Asia Pacific regions. The company has pursued strategic acquisitions and divestitures to strengthen its product lineup and expand its pipeline, demonstrating commitment to innovation in orthopedic solutions. With recent advancements including robotic-assisted surgical systems and iodine-treated implant technologies, Zimmer Biomet maintains a significant presence in the orthopedic reconstructive market. Founded in 1927 and headquartered in Warsaw, Indiana, the company operates as a key player in the medical device industry, focusing on improving musculoskeletal health outcomes globally.